Skip to main content
. 2021 Mar 5;9(3):221. doi: 10.3390/vaccines9030221
ACE-2 Angiotensin-Converting Enzyme 2
ACIP Advisory Committee on Immunization Practices
CARPA Complement Activation-related Pseudo-Allergy
CDC Centers for Disease Control
COVID-19 Coronavirus Disease 2019
EUA Emergency Use Authorization
EMA European Medicines Agency
FDA Food and Drug Administration
IgE Immunoglobulin E
IgG Immunoglobulin G
IgM Immunoglobulin M
LNP Lipid Nano Particles
MRGPRx2 Mas-related G Protein-Coupled Receptor X2
MMWR Morbidity and Mortality Weekly Report
PAF Platelet Activating Factor
PEG Polyethylene Glycol
RNA Ribonucleic Acid
mRNA messenger Ribonucleic Acid
SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2
VAERS Vaccine Adverse Events Reporting System (VAERS).